GCP
VRCA icon

GSA Capital Partners’s Verrica Pharmaceuticals VRCA Stock Holding History

GSA Capital Partners’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,855
Closed -$282K – 2000
2023
Q4 		$282K Buy
3,855
+1,534
+66% +$63K 0.02% 1145
2023
Q3 		$90K Sell
2,321
-1,496
-39% -$76K 0.01% 1394
2023
Q2 		$220K Buy
+3,817
New +$232K 0.02% 1214
2021
Q3 		– Sell
-9,326
Closed -$1.05M – 1806
2021
Q2 		$1.05M Buy
+9,326
New +$1.13M 0.12% 229

Other funds holding VRCA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return